Molecular markers of pancreatic cancer: development and clinical relevance (Q37081461)

18 August 2017

1 reference

title

Molecular markers of pancreatic cancer: development and clinical relevance (English)

1 reference

18 August 2017

1 reference

3

Peter Malfertheiner

1 reference

18 August 2017

Lucia C Fry

1

1 reference

PubMed ID

18266003

18 August 2017

Klaus Mönkemüller

series ordinal

2

1 reference

PubMed ID

18266003

18 August 2017

language of work or name

English

0 references

publication date

12 February 2008

1 reference

Langenbeck's Archives of Surgery

18 August 2017

1 reference

18 August 2017

393

1 reference

18 August 2017

6

1 reference

18 August 2017

883-890

1 reference

https://scigraph.springernature.com/pub.10.1007/s00423-007-0276-0

18 August 2017

0 references

cites work

Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-007-0276-0

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-007-0276-0

Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-007-0276-0

New tumor-associated antigen SC6 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-007-0276-0

The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-007-0276-0

Increased telomerase activities in human pancreatic duct adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-007-0276-0

Discovery of novel tumor markers of pancreatic cancer using global gene expression technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-007-0276-0

Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-007-0276-0

Prognostic value of CA 19-9 serum course in pancreatic cancer

21 January 2018

1 reference

12 December 2020

Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer

1 reference

12 December 2020

Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications

1 reference

12 December 2020

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas

1 reference

12 December 2020

Early detection of pancreatic carcinoma

1 reference

12 December 2020

Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas.

1 reference

12 December 2020

Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.

1 reference

12 December 2020

DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas.

1 reference

12 December 2020

Hypermethylation of multiple genes in pancreatic adenocarcinoma

1 reference

12 December 2020

The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection.

1 reference

12 December 2020

Molecular markers of early pancreatic cancer

1 reference

12 December 2020

Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases

1 reference

12 December 2020

DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease

1 reference

12 December 2020

1 reference

12 December 2020

Implications of growth factor alterations in the treatment of pancreatic cancer

1 reference

12 December 2020

Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer

1 reference

12 December 2020

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions

1 reference

12 December 2020

Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas

1 reference

12 December 2020

Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation

1 reference

12 December 2020

Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases

1 reference

12 December 2020

Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness

1 reference

12 December 2020

Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification

1 reference

12 December 2020

Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.

1 reference

12 December 2020

Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer

1 reference

12 December 2020

Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer

1 reference

12 December 2020

Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.

1 reference

12 December 2020

Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer

1 reference

12 December 2020

Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.

1 reference

12 December 2020

The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region

1 reference

12 December 2020

p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis

1 reference

12 December 2020

A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consec

1 reference

12 December 2020

Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms

1 reference

12 December 2020

1 reference

12 December 2020

Preoperative staging of periampullar cancer with US, CT, EUS and CA 19-9

1 reference

12 December 2020

Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.

1 reference

12 December 2020

Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions.

1 reference

12 December 2020

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers

1 reference

12 December 2020

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

1 reference

12 December 2020

Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression

1 reference

12 December 2020

Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer

1 reference

12 December 2020

American gastroenterological association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

1 reference

12 December 2020

Progression model for pancreatic cancer.

1 reference

12 December 2020

Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA

1 reference

12 December 2020

Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines

1 reference

12 December 2020

Pyruvate kinase type M2 and its role in tumor growth and spreading

1 reference

12 December 2020

Markedly elevated serum CA 19-9 levels in a case of chronic pancreatitis

1 reference

12 December 2020

Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9

1 reference

12 December 2020

Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy

1 reference

12 December 2020

Diagnosis of pancreatic cancer using serum proteomic profiling.

1 reference

12 December 2020

Mimicks of pancreatic malignancy in patients with chronic pancreatitis: correlation of computed tomography imaging features with histopathologic findings

1 reference

12 December 2020

The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3.

1 reference

12 December 2020

Detection of telomerase activity in patients with pancreatic cancer

1 reference

12 December 2020

Molecular analysis of pancreatic juice: a helpful tool to differentiate benign and malignant pancreatic tumors?

1 reference

12 December 2020

The clinical utility of the CA 19-9 tumor-associated antigen.

1 reference

12 December 2020

K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.

1 reference

12 December 2020

Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray

1 reference

12 December 2020

Lewis blood-type may affect the incidence of gastrointestinal cancer

1 reference

12 December 2020

p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness.

1 reference

12 December 2020

Tumor-suppressor p53: implications for tumor development and prognosis

1 reference

12 December 2020

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association

1 reference

12 December 2020

CA 19-9 as a prognostic index after resection for pancreatic cancer

1 reference

12 December 2020

Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications

1 reference

12 December 2020

Serum tumor markers and molecular biological diagnosis in pancreatic cancer.

1 reference

12 December 2020

Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer

1 reference

12 December 2020

Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters

1 reference

12 December 2020

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

1 reference

12 December 2020

Mucin-Type Glycoproteins

1 reference

12 December 2020

Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial

1 reference

12 December 2020

Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis

1 reference

12 December 2020

Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

1 reference

12 December 2020

Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer

1 reference

12 December 2020

Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins

1 reference

12 December 2020

Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion

1 reference

12 December 2020

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

12 December 2020

Possible detection of pancreatic cancer by plasma protein profiling

1 reference

12 December 2020

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression

1 reference

12 December 2020

10.1007/S00423-007-0276-0

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18266003